GDC-0349 treatment (100 nM for 2 h) blocked Akt-S6K1 phosphorylation in primary NSCLC cells, NSCLC-1 (Fig. 3b) and NSCLC-2 (Fig. 3c). This evidence concerns the gene AKT1 and non-small cell lung carcinoma.